Ziagen is the brand name for the antiretroviral drug abacavir used in the treatment of hiv infection. It works by inhibiting the viral reverse transcriptase enzyme, which prevents the conversion of rna into dna and thereby halts viral replication. The drug binds to the active site of reverse transcriptase, reducing the enzyme's ability to synthesize viral genetic material. When taken as prescribed, abacavir decreases the amount of virus in the bloodstream, allowing the immune system to stabilize and slow disease progression. Its therapeutic effect is achieved through daily oral dosing, with absorption occurring in the small intestine and metabolism primarily by the liver. Common side effects include hypersensitivity reactions that require genetic testing before initiation to prevent severe immune responses.

Ziagen is an antiretroviral medication classified as a nucleoside reverse transcriptase inhibitor. It is indicated for the treatment of hiv infection when used in combination with other antiretroviral agents. The drug works by being metabolized into its active form abacavir triphosphate which mimics the natural substrate for the viral reverse transcriptase enzyme. This active metabolite competes with deoxyadenosine triphosphate and is incorporated into the growing viral dna chain. Incorporation terminates dna synthesis preventing the virus from replicating its genetic material. By reducing viral replication the medication helps control infection and supports immune function.

Ziagen may cause peripheral neuropathy which can lead to numbness or tingling in the hands and feet. Some people experience liver problems such as elevated enzymes or jaundice. Gastrointestinal upset including nausea or loss of appetite has been reported. Kidney function can be affected resulting in decreased urine output or changes in blood test results. Rash or skin discoloration may occur in certain individuals. Fatigue or general weakness is another frequently observed symptom. Blood cell counts such as low platelets or white blood cells may occasionally be noted.

Common side effects of Ziagen may include nausea, headache, and fatigue. Some patients also report difficulty sleeping, dizziness, or mild rash. Blood-related changes such as low red blood cell count can occur. Gastrointestinal symptoms like abdominal pain or loss of appetite are occasionally observed. Liver function test abnormalities may be detected during routine monitoring. Rarely, muscle pain or weakness has been reported in clinical studies. Most of these effects are mild and often improve with continued use.